Tirzepatide Compounding Update: FDA Reversal & What Pharmacies Need to Know! | Becoming A Pharmacy Badass
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
**Dr. Lisa Faast shares important news about tirzepatide compounding. After a shortage, the FDA reversed its decision and now allows pharmacies to compound and sell tirzepatide again. She covers the latest updates, suppliers like Lone Star Pharmaceuticals, BPI Labs, and PQ Pharma, and tips on staying compliant with state boards. Stay informed by joining the APC Alliance.**
**Show Notes:**
1. **FDA Reversal on Tirzepatide Compounding** [0:00]
2. **Clarification from the FDA ** [2:51]
3. **Availability and Cost of Tirzepatide ** [5:09]
4. **State Regulations and Documentation** [6:31]
5. **Final Thoughts and Resources** [7:02]
<br>
**Websites Mentioned:
https://lonestarpharmaceuticals.com/
https://bpilabs.com/
https://www.pqpharmacy.com/s/
https://diversifyrx.com/weekly-awesomeness-newsletter/
https://www.drlisafaast.com/
-----
#### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**